These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
554 related items for PubMed ID: 6863937
1. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection. James SL, Skamene E, Meltzer MS. J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937 [Abstract] [Full Text] [Related]
2. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens. James SL, Lazdins JK, Hieny S, Natovitz P. J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456 [Abstract] [Full Text] [Related]
3. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses. James SL, Correa-Oliveira R, Leonard EJ. J Immunol; 1984 Sep; 133(3):1587-93. PubMed ID: 6431002 [Abstract] [Full Text] [Related]
4. Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection. James SL, Sher A, Lazdins JK, Meltzer MS. J Immunol; 1982 Apr; 128(4):1535-40. PubMed ID: 7061842 [Abstract] [Full Text] [Related]
5. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. II. Response of mouse strains with selective immune defects. James SL, DeBlois LA. J Immunol; 1986 May 15; 136(10):3864-71. PubMed ID: 3084645 [Abstract] [Full Text] [Related]
6. Modulation of macrophage activation and resistance by suppressor T lymphocytes in chronic murine Schistosoma mansoni infection. Olds GR, Ellner JJ. J Immunol; 1984 Nov 15; 133(5):2720-4. PubMed ID: 6237154 [Abstract] [Full Text] [Related]
7. Defective vaccine-induced resistance to Schistosoma mansoni in P strain mice. III. Specificity of the associated defect in cell-mediated immunity. James SL, Deblois LA, Al-Zamel F, Glaven J, Langhorne J. J Immunol; 1986 Dec 15; 137(12):3959-67. PubMed ID: 3097138 [Abstract] [Full Text] [Related]
8. Macrophages in resistance to rickettsial infections: genetic analysis of susceptibility to lethal effects of Rickettsia akari infection and development of activated, cytotoxic macrophages in A and B10.a mice. Meltzer MS, Nacy CA, Stevenson MM, Skamene E. J Immunol; 1982 Oct 15; 129(4):1719-23. PubMed ID: 6896718 [Abstract] [Full Text] [Related]
9. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. Boraschi D, Meltzer MS. J Immunol; 1980 Aug 15; 125(2):771-6. PubMed ID: 6993562 [Abstract] [Full Text] [Related]
10. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella. Schafer R, Nacy CA, Eisenstein TK. J Immunol; 1988 Mar 01; 140(5):1638-44. PubMed ID: 3279120 [Abstract] [Full Text] [Related]
11. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvacidal macrophages. James SL. J Immunol; 1986 May 15; 136(10):3872-7. PubMed ID: 3084646 [Abstract] [Full Text] [Related]
12. Macrophages as effector cells of protective immunity in murine schistosomiasis. III. Loss of susceptibility to macrophage-mediated killing during maturation of S. mansoni schistosomula from the skin to the lung stage. Sher A, James SL, Simpson AJ, Lazdins JK, Meltzer MS. J Immunol; 1982 Apr 15; 128(4):1876-9. PubMed ID: 7061853 [Abstract] [Full Text] [Related]
13. In vitro killing of S. mansoni schistosomula by lymphokine-activated mouse macrophages. Bout DT, Joseph M, David JR, Capron AR. J Immunol; 1981 Jul 15; 127(1):1-5. PubMed ID: 7240738 [Abstract] [Full Text] [Related]
14. The interactions between macrophages and developmental stages of Schistosoma mansoni: effect of macrophage function modulators on the viability of S. mansoni in vivo and in vitro. Malkin R, Flescher E, Lengy J, Keisari Y. J Biol Response Mod; 1986 Oct 15; 5(5):470-80. PubMed ID: 3095497 [Abstract] [Full Text] [Related]
15. Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes. Nacy CA, Meltzer MS, Fortier AH. J Immunol; 1984 Dec 15; 133(6):3344-50. PubMed ID: 6491291 [Abstract] [Full Text] [Related]
16. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. Boraschi D, Meltzer MS. J Immunol; 1979 Apr 15; 122(4):1587-91. PubMed ID: 376720 [Abstract] [Full Text] [Related]
17. Defective tumoricidal capacity of macrophages from C3H/HeJ mice. Ruco LP, Meltzer MS. J Immunol; 1978 Jan 15; 120(1):329-34. PubMed ID: 627723 [Abstract] [Full Text] [Related]
18. Identification of a genetic locus, Rsm-1, controlling protective immunity against Schistosoma mansoni. Correa-Oliveira R, James SL, McCall D, Sher A. J Immunol; 1986 Sep 15; 137(6):2014-9. PubMed ID: 3091695 [Abstract] [Full Text] [Related]
19. Amphotericin B-induced resistance to Schistosoma mansoni. Olds GR, Stewart SJ, Ellner JJ. J Immunol; 1981 May 15; 126(5):1667-70. PubMed ID: 7217661 [Abstract] [Full Text] [Related]
20. Tumoricidal macrophages isolated from liver granulomas of Schistosoma mansoni-infected mice. Loveless SE, Wellhausen SR, Boros DL, Heppner GH. J Immunol; 1982 Jan 15; 128(1):284-8. PubMed ID: 7054278 [Abstract] [Full Text] [Related] Page: [Next] [New Search]